© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 5.89% of QNRX shares are held by financial institutions. ADVISORY SERVICES NETWORK, LLC is the top corporate investor, holding 2K shares valued at $951.00. A 0.03% stake in Quoin Pharmaceuticals, Ltd. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
Among the QNRX insiders holding of 2.45% of the stake in company, CARTER DENISE P., Chief Operating Officer, holds the largest shares of 555.56K. MYERS MICHAEL, Chief Executive Officer, is the second largest QNRX insider with ownership of 555.56K shares. DUNN GORDON, Chief Financial Officer, stands third with possession of 122.22K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own QNRX shares is 11, representing 5.89% of the company's common stock.
ADVISORY SERVICES NETWORK, LLC, in the last quarter, reduced its stake in QNRX by -50% restricting it's holding to 2 thousand shares of worth nearly $951.00. N/A also lessened N/A of the QNRX shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned QNRX shares holding by N/A last quarter which brought its holding to - shares worth -.
As per its latest 13F filing, N/A increased its stake in QNRX by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of QNRX to its portfolio, raising its holding to - shares of worth -. N/A also increased its QNRX shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in QNRX is Carter Denise P. , Chief Operating Officer at the company. Additionally, QNRX stock is highly held by Chief Executive Officer Myers Michael and Chief Financial Officer Dunn Gordon among others.
Company executives, directors, and other insiders own 2.45% percent of Quoin Pharmaceuticals, Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which QNRX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include LANGER DENNIS.
There have been 10 transaction(s) during the past 6-months in which Quoin Pharmaceuticals, Ltd. insiders have bought stock, totalling 1360958 shares
Around 1.41M Quoin Pharmaceuticals, Ltd. shares are held by insiders, which represents about 2.45% of QNRX stock.
QNRX Chief Operating Officer, Carter Denise P. holds the largest portfolio of the company's shares. QNRX shares owned by Carter total nearly 555.56 thousand.
ADVISORY SERVICES NETWORK, LLC is the largest institutional owner in QNRX which holds 2 thousand shares worth $951.00 or 0.03% of the total QNRX shares outstanding followed by N/A with ownership of - shares representing N/A of the QNRX ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the QNRX is concerned, it is a stock which is not optionable.
Number of QNRX shares short is 19.17K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 8.19M shares of QNRX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, QNRX has 3.88M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for QNRX is 0.2.